Top

Category: Pharma


Industry, Pharma

Pharma’s climate change vulnerability and opportunity

September 9, 2022

Via: Pharmaphorum

Pharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. But preparing to adapt to the phenomenon presents an opportunity as well as a challenge. Rising global temperatures will, […]


Industry, Pharma

Now is the time for pharma to help solve bias in clinical trials

September 7, 2022

Via: Pharmaphorum

The industry’s application of mRNA techniques during the pandemic led to the fastest vaccine development in history. The processes used are now seeing huge infrastructure commitments, in order to cement their place in the development of future products and trials. […]


Industry, Pharma

How can the pharma industry address the gap in talent recruitment and development?

August 4, 2022

Via: Pharmaphorum

In particular, for the pharmaceutical industry, these talent shortages bring about a host of difficult challenges. This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. […]


Industry, Pharma

Everything You Need to Know About Paxlovid — Especially, Should You Take It?

July 28, 2022

Via: Kaiser Health News

When President Joe Biden tested positive for covid-19 on July 21, his physician recommended he take the antiviral drug Paxlovid. The drug significantly reduces the likelihood of hospitalization or death for someone at high risk of developing severe covid. Biden […]


Industry, Pharma

Sandoz’s application for MS biosimilar accepted by FDA

July 25, 2022

Via: PMLiVE

The application incorporates all indications covered by the reference medicine, Biogen’s Tysabri (natalizumab), for relapsing forms of MS, including clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), active secondary progressive disease in adults and Crohn’s disease. A marketing authorisation application (MAA) […]


Industry, Pharma, Pricing, Regulations

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe

July 22, 2022

Via: Pharmaphorum

The CMA delivered a preliminary judgment in the case last year which concluded that Pfizer and Flynn abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to balloon from around £2 million a year in 2012 to […]


Industry, Pharma

Parents Become Drug Developers to Save Their Children’s Lives

July 21, 2022

Via: Kaiser Health News

Maggie Carmichael wasn’t developing like other kids. As a toddler, she wasn’t walking and had a limited vocabulary for her age. She was diagnosed with PMM2-CDG, potentially fatal gene mutations that cause abnormal enzyme activity — and affect fewer than […]


Industry, Pharma

NICE recommends Rhythm Pharmaceuticals’ Imcivree for severe obesity and hyperphagia

July 19, 2022

Via: PMLiVE

The National Institute for Health and Care Excellence (NICE) has recommended Rhythm Pharmaceuticals’ Imcivree (setmelanotide) as a treatment for hyperphagia (insatiable hunger) and early onset severe obesity. The recommendation follows positive results from clinical trials suggesting that Imcivree may reduce […]


Industry, Pharma

As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing Stronger

July 15, 2022

Via: Kaiser Health News

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics. There’s […]


Industry, Pharma

NICE backs two new breast cancer drugs for NHS use

July 14, 2022

Via: Pharmaphorum

In a statement, the health technology assessment (HTA) organisation said that the two drugs were backed after an agreement with the two developers on pricing that will make them an option for around 3,450 NHS patients. Trodelvy (sacituzumab govitecan) can […]


Industry, Pharma

HRA Pharma bids to bring first OTC contraceptive pill to US

July 12, 2022

Via: Pharmaphorum

The move comes as access to birth control becomes a pivotal issue following the landmark ruling by the Supreme Court last month to strip US women of their constitutional protection for the right to abortion, although the company says that […]


Industry, Pharma

Innoviva builds in infectious diseases with La Jolla Pharma buy

July 12, 2022

Via: Pharmaphorum

The deal centres on La Jolla’s lead product Giapreza (angiotensin II), used to increase blood pressure in adults with septic shock, and antibiotic Xerava (eravacycline) for complicated intra-abdominal infections (cIAIs), approved by the FDA in 2017 and 2018, respectively. La […]


Industry, Mergers and Acquisitions, Pharma, Vaccines

Preventing the next pandemic: Supporting early-stage R&D

July 7, 2022

Via: Pharmaphorum

When COVID-19 first emerged, scientists cautioned that developing an effective and safe vaccine could take longer than the commonly estimated figure of a year. The reason for the caution was that the previous quickest turnaround of a vaccine was for […]


Industry, Pharma

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

June 29, 2022

Via: Pharmaphorum

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. However, this picture of recovery hides a […]


Industry, Pharma

Relay details new research plans in quest to design better cancer drugs

June 27, 2022

Via: Biopharma Dive

Relay has raised more than $1 billion on the promise that its protein motion technology can help it discover and develop better drugs in less time. Its efforts remain in early stages and, so far, don’t prove its approach can […]


Industry, Pharma

US frets over pharma supply chain security

June 22, 2022

Via: Pharmaphorum

In a global economy, across a number of industries, low-margin products are often manufactured in countries where labour is cheap. The pharmaceutical industry is no different, with India and China becoming two of the leading manufacturers and exporters of generic […]


Industry, Pharma

Bora Pharmaceuticals to Expand Operations

April 21, 2022

Via: Contract Pharma

Bora Pharmaceuticals, a fast-growing contract development and manufacturing organization (CDMO), is investing more than $10 million over the next 2 years to expand its oral solid dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario. The company’s CEO, Bobby […]


Industry, Pharma

FDA Revives Initiative to Identify and Reward Quality Drug Operations

April 12, 2022

Via: Biopharm International

To further encourage pharmaceutical companies to invest in the reliable production of higher quality products, FDA is reviving efforts to establish a Quality Management Maturity (QMM) program. An updated version of this approach is spelled out in a new White […]


FDA, Industry, Pharma, Regulations

FDA halts use of GlaxoSmithKline and Vir’s COVID-19 drug Xevudy in 8 northeast states

March 28, 2022

Via: FiercePharma

With new strains of the coronavirus showing their elusiveness and pushing more antibody treatments toward irrelevance, is there danger of an over-reliance on COVID-19 oral antivirals, especially Pfizer’s Paxlovid? Friday, the U.S. paused the distribution of GlaxoSmithKline and Vir Biotechnology’s […]


Industry, Pharma

Bayer plots $1.6B investment at German pharma manufacturing sites, with digital transformation a key component

March 3, 2022

Via: FiercePharma

If you think Bayer’s recent $180 million sale of a drug manufacturing facility in Germany means the company is scaling back on production in its home country, think again. Bayer plans to invest 1.4 billion euros ($1.55 billion) in its […]